NET PROFIT (x1000 EUR)
EMPLOYEES
ERCO Pharma AB
Closing information (x1000 EUR)
| Closing information | 2023/12 | 2022/12 | 2021/12 |
| Turnover |
0
|
0
|
0 |
| Financial expenses |
0
|
0
|
0 |
| Earnings before taxes |
-272
|
-447
|
-332 |
| EBITDA |
-269
|
-443
|
-310 |
| Total assets |
10
|
103
|
26 |
| Current assets |
10
|
100
|
19 |
| Current liabilities |
5
|
99
|
21 |
| Equity capital |
5
|
5
|
5 |
| - share capital |
5
|
4
|
5 |
| Employees (average) |
2
|
3
|
3 |
Financial ratios
| Fiscal year | 2023/12 | 2022/12 | 2021/12 |
| Solvency |
50.0%
|
4.9%
|
19.2% |
| Turnover per employee |
0
|
0
|
0 |
| Profit as a percentage of turnover | |||
| Return on assets (ROA) |
-2720.0%
|
-434.0%
|
-1276.9% |
| Current ratio |
200%
|
101.0%
|
90.5% |
| Return on equity (ROE) |
-5440.0%
|
-8940.0%
|
-6640.0% |
| Change turnover |
0
|
0
|
0 |
| Change turnover % | |||
| Chg. No. of employees |
-1
|
0
|
0 |
| Chg. No. of employees % |
-33%
|
0%
|
0% |
Total value of public sale
| Fiscal year | 2023/12 | 2022/12 | 2021/12 |
| Total value of public sale |
0
|
0
|
0 |
Closing figures are converted to the currency above at the exchange rate of the closing date. Source for the exchange rates: Sveriges Riksbank
The closing information is gathered directly from the companies or from Creditsafe.